CMS’ Use Of Data From “Coverage With Evidence Development” Process To Vary
This article was originally published in The Pink Sheet Daily
Executive Summary
The way data are used will depend on whether information is gathered through a clinical trial, registry or other method, CMS’ Phurrough says. Most data collection methods will not support a change in a national coverage determination, although such information will assist in clinical practice.